Ubs Group Ag Legend Biotech Corp Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Legend Biotech Corp stock. As of the latest transaction made, Ubs Group Ag holds 1,021,556 shares of LEGN stock, worth $32.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,021,556

Previous 961,175 6.28%

Holding current value

$32.1 Million

Previous $32.6 Million 11.17%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$27.69 - $37.91 $1.67 Million - $2.29 Million	60,381 Added 6.28%	1,021,556 $36.3 Million
Q1 2025 May 13, 2025	SELL	$31.43 - $39.7 $592,864 - $748,861	-18,863 Reduced 1.92%	961,175 $32.6 Million
Q4 2024 Feb 14, 2025	BUY	$32.49 - $50.28 $28 Million - $43.3 Million	861,920 Added 729.71%	980,038 $31.9 Million
Q3 2024 Nov 14, 2024	SELL	$43.55 - $59.88 $66,239 - $91,077	-1,521 Reduced 1.27%	118,118 $5.76 Million
Q2 2024 Aug 13, 2024	SELL	$39.5 - $57.22 $334,841 - $485,053	-8,477 Reduced 6.62%	119,639 $5.3 Million
Q1 2024 May 13, 2024	SELL	$55.06 - $69.99 $9.42 Million - $12 Million	-171,127 Reduced 57.19%	128,116 $7.19 Million
Q4 2023 Feb 09, 2024	SELL	$57.25 - $69.74 $133,507 - $162,633	-2,332 Reduced 0.77%	299,243 $18 Million
Q3 2023 Nov 09, 2023	BUY	$63.16 - $76.5 $10.1 Million - $12.3 Million	160,446 Added 113.69%	301,575 $20.3 Million
Q2 2023 Aug 11, 2023	SELL	$46.28 - $75.01 $112,784 - $182,799	-2,437 Reduced 1.7%	141,129 $9.74 Million
Q1 2023 May 12, 2023	BUY	$43.42 - $57.37 $1.45 Million - $1.92 Million	33,509 Added 30.45%	143,566 $6.92 Million
Q4 2022 Feb 08, 2023	BUY	$38.8 - $55.46 $456,520 - $652,542	11,766 Added 11.97%	110,057 $5.49 Million
Q3 2022 Nov 10, 2022	BUY	$38.15 - $57.1 $372,382 - $557,353	9,761 Added 11.03%	98,291 $4.01 Million
Q2 2022 Aug 10, 2022	SELL	$33.54 - $55.0 $438,200 - $718,575	-13,065 Reduced 12.86%	88,530 $4.87 Million
Q1 2022 May 16, 2022	SELL	$31.02 - $48.18 $25,095 - $38,977	-809 Reduced 0.79%	101,595 $3.69 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $1.88 Million - $2.61 Million	45,748 Added 80.75%	102,404 $4.77 Million
Q3 2021 Nov 15, 2021	BUY	$35.31 - $50.56 $1.92 Million - $2.75 Million	54,366 Added 2374.06%	56,656 $2.86 Million
Q2 2021 Aug 13, 2021	BUY	$25.8 - $41.09 $11,171 - $17,791	433 Added 23.32%	2,290 $94,000
Q1 2021 May 12, 2021	SELL	$23.55 - $32.4 $2,661 - $3,661	-113 Reduced 5.74%	1,857 $54,000
Q4 2020 Feb 11, 2021	BUY	$25.8 - $32.39 $20,691 - $25,976	802 Added 68.66%	1,970 $55,000
Q3 2020 Nov 12, 2020	BUY	$27.5 - $39.61 $18,370 - $26,459	668 Added 133.6%	1,168 $36,000
Q2 2020 Jul 31, 2020	BUY	$36.1 - $42.56 $18,050 - $21,280	500 New	500 $21,000

Others Institutions Holding LEGN

# of Institutions

237

Shares Held

60M

Call Options Held

591K

Put Options Held

381K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.26B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account